Pilot evaluation of Vivalytic instrument for detection of UTIs
Research type
Research Study
Full title
Pilot study evaluating the use of the Vivalytic Instrument for the detection of Urinary Tract Infections (UTIs)
IRAS ID
347381
Contact name
Aaron Peace
Contact email
Sponsor organisation
Randox Laboratories Ltd
Duration of Study in the UK
3 years, 0 months, 1 days
Research summary
Background: Urinary tract infections (UTIs) are, unfortunately, a relatively common condition that can warrant a course of antibiotics. However, the severity of disease that these infections can cause in certain patient groups is often overlooked. In England, there were over 1.8 million hospital admissions involving UTIs between 2018-19 and 2022-23 (https://www.england.nhs.uk/2023/10/new-awareness-campaign-to-help-reduce-hospital-admissions-for-urinary-tract-infections/). Risk remains highest in patients over 65 years of age, with a large proportion of those patients being 80-84 years of age. Prescribing the correct treatment following an expedient diagnosis is of utmost importance, particularly in the context of advancing age and multi-morbidities. Reducing the prescribing of broad spectrum antibiotics as a first line treatment should be prioritised to reduce risks of antibiotic resistance.
Current UTI diagnosis involves culturing the patient’s urine sample on multiple culture plates in incubators at specific temperatures in the microbiology laboratory and viewing of the same plates, after time has been allowed, for growth of microorganisms that cause the infections. This can take over 3 days, and is labour and resource intensive - requiring multiple culture plates, reagents and incubators.
The Vivalytic UTI test used on the point-of-care instrument uses a small volume of urine (< 0.5ml; <half a teaspoon) to detect various bacteria that cause UTIs. The UTI test also detects for the resistance of some bacteria to common antibiotics so that healthcare providers in the future could offer patients treatment, that is more tailored/effective for the individual, in under 3 hours. Earlier diagnosis of the cause of the UTI would enable patients to receive appropriate treatment more quickly, improving patient outcomes and reducing hospital resources.
Aims/research questions: The aim of this 3 year study is to provide evidence to assist with adoption of the UTI test and point-of-care instrument (1) by comparing time to results between standard laboratory culture methods and the UTI test on the point-of-care instrument, and (2) obtaining feedback detailing the ease of use of the new system from healthcare professionals.
Objectives: This is a pilot study to run a urine sample on the UTI test using the point-of-care Vivalytic device to:1) Receive feedback from staff untrained on the instrument on how easy or difficult the test and instrument are to use.
2) Record the result from the UTI test and the result from the microbiology culture
3) Determine if treatment would have been different if the result from the UTI test was available/used. (Note: no changes to standard of care in this study).
4) Record the length of time taken to obtain results from the Trust laboratory vs. results from the UTI test on the Vivalytic.
5) Assess the ease of interpretation of the results from the UTI test on the Vivalytic.REC name
West Midlands - Edgbaston Research Ethics Committee
REC reference
25/WM/0206
Date of REC Opinion
17 Oct 2025
REC opinion
Favourable Opinion